These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24377923)

  • 1. Assessment of the Toll-like receptor 3 pathway in endosomal signaling.
    Matsumoto M; Funami K; Tatematsu M; Azuma M; Seya T
    Methods Enzymol; 2014; 535():149-65. PubMed ID: 24377923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral responses induced by the TLR3 pathway.
    Matsumoto M; Oshiumi H; Seya T
    Rev Med Virol; 2011 Mar; 21(2):67-77. PubMed ID: 21312311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.
    Seya T; Matsumoto M; Ebihara T; Oshiumi H
    Immunol Rev; 2009 Jan; 227(1):44-53. PubMed ID: 19120474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo.
    Matsumoto M; Tatematsu M; Nishikawa F; Azuma M; Ishii N; Morii-Sakai A; Shime H; Seya T
    Nat Commun; 2015 Feb; 6():6280. PubMed ID: 25692975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR3: interferon induction by double-stranded RNA including poly(I:C).
    Matsumoto M; Seya T
    Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-IL-1-receptor-containing adaptor molecule-1: a signaling adaptor linking innate immunity to adaptive immunity.
    Matsumoto M; Funami K; Oshiumi H; Seya T
    Prog Mol Biol Transl Sci; 2013; 117():487-510. PubMed ID: 23663980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling.
    Johnsen IB; Nguyen TT; Ringdal M; Tryggestad AM; Bakke O; Lien E; Espevik T; Anthonsen MW
    EMBO J; 2006 Jul; 25(14):3335-46. PubMed ID: 16858407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral signaling through pattern recognition receptors.
    Kawai T; Akira S
    J Biochem; 2007 Feb; 141(2):137-45. PubMed ID: 17190786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
    Alexopoulou L; Holt AC; Medzhitov R; Flavell RA
    Nature; 2001 Oct; 413(6857):732-8. PubMed ID: 11607032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
    Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
    Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.
    Vanhoutte F; Paget C; Breuilh L; Fontaine J; Vendeville C; Goriely S; Ryffel B; Faveeuw C; Trottein F
    Immunol Lett; 2008 Feb; 116(1):86-94. PubMed ID: 18166232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
    Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
    Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.
    Takeda Y; Kataoka K; Yamagishi J; Ogawa S; Seya T; Matsumoto M
    Cell Rep; 2017 May; 19(9):1874-1887. PubMed ID: 28564605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta induction through toll-like receptor 3 depends on double-stranded RNA structure.
    Okahira S; Nishikawa F; Nishikawa S; Akazawa T; Seya T; Matsumoto M
    DNA Cell Biol; 2005 Oct; 24(10):614-23. PubMed ID: 16225392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.
    Matsumoto M; Kikkawa S; Kohase M; Miyake K; Seya T
    Biochem Biophys Res Commun; 2002 May; 293(5):1364-9. PubMed ID: 12054664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses.
    Tatematsu M; Seya T; Matsumoto M
    Biochem J; 2014 Mar; 458(2):195-201. PubMed ID: 24524192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular double-stranded RNA induces TSLP via an endosomal acidification- and NF-κB-dependent pathway in human keratinocytes.
    Vu AT; Chen X; Xie Y; Kamijo S; Ushio H; Kawasaki J; Hara M; Ikeda S; Okumura K; Ogawa H; Takai T
    J Invest Dermatol; 2011 Nov; 131(11):2205-12. PubMed ID: 21716324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.